rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-12-13
|
pubmed:abstractText |
Use of prescription nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) increases the risk of serious upper gastrointestinal toxicity. Less is known about over-the-counter (OTC) NANSAIDs, which are typically used at lower doses and for shorter durations. This study assessed the risk of toxicity with OTC NANSAIDs.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0016-5085
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
129
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1865-74
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16344055-Adult,
pubmed-meshheading:16344055-Aged,
pubmed-meshheading:16344055-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:16344055-Gastrointestinal Diseases,
pubmed-meshheading:16344055-Gastrointestinal Hemorrhage,
pubmed-meshheading:16344055-Humans,
pubmed-meshheading:16344055-Ibuprofen,
pubmed-meshheading:16344055-Male,
pubmed-meshheading:16344055-Middle Aged,
pubmed-meshheading:16344055-Naproxen,
pubmed-meshheading:16344055-Nonprescription Drugs,
pubmed-meshheading:16344055-Random Allocation,
pubmed-meshheading:16344055-Risk Factors,
pubmed-meshheading:16344055-Upper Gastrointestinal Tract
|
pubmed:year |
2005
|
pubmed:articleTitle |
Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
|
pubmed:affiliation |
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. jlewis@cceb.med.upenn.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|